NASDAQ:LVTX
Delisted

Lava Therapeutics B.v Stock Signals

etoro logo Buy LVTX
*Your capital is at risk
$1.74
+0 (+0%)
At Close: Feb 27, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Lava Therapeutics B.V.

General

Signal Type Signal Value Data
Score 0.000 84 days ( -8.07 %
Last Price $1.74 0 %
Performance History
7 Days
$1.74 $1.74
0%
30 Days
$1.74 $1.74
0%
12 Mos
$1.29 $1.74
34.88%

8/18

Active Buy Signals

Specific Signals

Short Term
Net score: 30.41
Signal Type Signal Value Importance Data
High / Low N/A Very Low $1.74 - $1.74
Trend - 3 mos 0 % High Width: 0.00000000000020 %
Pred. range - 3 mos $1.74 - $1.74 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Feb 26, 2026 - 2 days
RSI Short Pivot Signal Buy Very Low Dec 09, 2025 - 55 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Jan 06, 2026 - 37 days
Short/Long MA 3 mos Sell Medium Jan 06, 2026 - 37 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 65.75
Signal Type Signal Value Importance Data
Trend - 12 mos 43.23 % Very High Width: 25.79 %
Pred. range - 12 mos $2.33 - $2.93 High 33.81 % - 68.32 %
Short MA 12 mos Sell Very High Dec 15, 2025 - 51 days
Long MA 12 mos Buy Very High Apr 15, 2025 - 219 days
Short/Long MA 12 mos Buy Very High Mar 20, 2025 - 237 days
Pivot Long Sell Low Nov 19, 2025 - 68 days
RSI Long Pivot Signal Buy Low Dec 18, 2025 - 48 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT LAVA THERAPEUTICS B.V.
Lava Therapeutics B.V
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for b...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE